Conversely, a significant amelioration in tumor incidence, visible tumor number per mouse, maximal tumor size and accumulated tumor size was observed in Ar deficient B6 mice (KO/B6) as compared to the control mice (WT/B6) (Figure 5), with a few minor exceptions. This evidence concerns the gene AR and neoplasm.